These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38099938)

  • 1. Retraction Note: Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.
    Haddadi R; Eyvari-Brooshghalan S; Nayebi AM; Sabahi M; Ahmadi SA
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):635. PubMed ID: 38099938
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.
    Haddadi R; Eyvari-Brooshghalan S; Nayebi AM; Sabahi M; Ahmadi SA
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2427-2437. PubMed ID: 32715318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats.
    Haddadi R; Nayebi AM; Eyvari Brooshghalan S
    Biomed Pharmacother; 2018 Aug; 104():127-136. PubMed ID: 29772432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction Notice to "Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats" [Biomed. Pharmacother. 104 (2018) 127-136].
    Haddadi R; Nayebi AM; Brooshghalan SE
    Biomed Pharmacother; 2024 Jan; 170():116044. PubMed ID: 38129200
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
    Baluchnejadmojarad T; Roghani M; Mafakheri M
    Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
    Haddadi R; Mohajjel Nayebi A; Brooshghalan SE
    Neurosci Lett; 2013 Oct; 555():106-11. PubMed ID: 24045063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.
    Haddadi R; Eyvari Brooshghalan S; Farajniya S; Mohajjel Nayebi A; Sharifi H
    Adv Pharm Bull; 2015 Nov; 5(4):463-9. PubMed ID: 26819917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
    Haddadi R; Poursina M; Zeraati F; Nadi F
    Inflammopharmacology; 2018 Oct; 26(5):1305-1316. PubMed ID: 29616453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study.
    Haddadi R; Nayebi AM; Farajniya S; Brooshghalan SE; Sharifi H
    Daru; 2014 Apr; 22(1):38. PubMed ID: 24726284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1.
    Zhang FL; He Y; Zheng Y; Zhang WJ; Wang Q; Jia YJ; Song HL; An HT; Zhang HB; Qian YJ; Tong YL; Dong L; Wang XM
    CNS Neurosci Ther; 2014 Dec; 20(12):1036-44. PubMed ID: 25399812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.
    Wang Y; Qu L; Wang XL; Gao L; Li ZZ; Gao GD; Yang Q
    Mol Neurobiol; 2015 Feb; 51(1):424-36. PubMed ID: 24841382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lesions in the pars compacta substantiae nigra and the subthalamic nucleus modify the density of muscarinic receptors in different nuclei of the basal ganglia].
    Blanco-Lezcano L; Rocha-Arrieta LL; Martínez-Martí L; Alvarez-González L; Pavón-Fuentes N; Macías-González R; Serrano-Sánchez T; Rosillo-Martí JC; Coro-Grave de Peralta Y; Bauza-Calderín Y; Briones M
    Rev Neurol; 2004 Jan 16-31; 38(2):128-32. PubMed ID: 14752710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-OHDA induced calcium influx through N-type calcium channel alters membrane properties via PKA pathway in substantia nigra pars compacta dopaminergic neurons.
    Qu L; Wang Y; Zhang HT; Li N; Wang Q; Yang Q; Gao GD; Wang XL
    Neurosci Lett; 2014 Jul; 575():1-6. PubMed ID: 24861516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease.
    Sophiabadi M; Rastgoo N; Haghdoost-Yazdi H
    Biol Trace Elem Res; 2022 Sep; 200(9):4058-4067. PubMed ID: 34741694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tempol and silymarin rescue from zinc-induced degeneration of dopaminergic neurons through modulation of oxidative stress and inflammation.
    Singh G; Mittra N; Singh C
    Mol Cell Biochem; 2023 Aug; 478(8):1705-1718. PubMed ID: 36562918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.
    Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F
    Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease.
    Latchoumycandane C; Anantharam V; Jin H; Kanthasamy A; Kanthasamy A
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):314-23. PubMed ID: 21846476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of silymarin on sodium fluoride-induced toxicity and oxidative stress in rat cardiac tissues.
    Nabavi SM; Nabavi SF; Moghaddam AH; Setzer WN; Mirzaei M
    An Acad Bras Cienc; 2012 Dec; 84(4):1121-6. PubMed ID: 22964841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.
    Suzuki K; Okada K; Wakuda T; Shinmura C; Kameno Y; Iwata K; Takahashi T; Suda S; Matsuzaki H; Iwata Y; Hashimoto K; Mori N
    PLoS One; 2010 Feb; 5(2):e9260. PubMed ID: 20174647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.